Neurol. praxi. 2017;18(5):348-351 | DOI: 10.36290/neu.2017.041

In the shadow of cerebral palsy: a case of ADCY5 related dyskinesias

MUDr. Ján Necpál1, MUDr. Matej ©korvánek, PhD.2
1 Neurologické oddelenie, Nemocnica Zvolen
2 Neurologická klinika, LF UPJ© a UNLP, Koąice

We report a case of 39 years old woman diagnosed with dyskinetic cerebral palsy and perinatal hypoxic encephalopathy. Two yearsafter a complicated delivery, paroxysmal choreatic limb movements, which became generalized and persistent later on, graduallydeveloped. After many years, a mutation in ADCY5 gene was identified through whole exome sequencing, which is probably thefirst reported case of ADCY5 related dyskinesias in Slovakia. We present a case report of the patient and a brief summary of theessential facts about this recently described condition.

Keywords: ADCY5, cerebral palsy, paroxysmal dyskinesias, case report

Received: September 4, 2017; Accepted: September 11, 2017; Published: November 1, 2017  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Necpál J, ©korvánek M. In the shadow of cerebral palsy: a case of ADCY5 related dyskinesias. Neurol. praxi. 2017;18(5):348-351. doi: 10.36290/neu.2017.041.

Video

Download citation

References

  1. Carecchio M, Mencacci NE, Iodice A, Pons R, Panteghini C, Zorzi G, Zibordi F, Bonakis A, Dinopoulos A, Jankovic J, Stefanis L, Bhatia KP, Monti V, R'Bibo L, Veneziano L, Garavaglia B, Fusco C, Wood N, Stamelou M, Nardocci N. ADCY5-related movement disorders: Frequency, disease course and phenotypic variability in a cohort of paediatric patients. Parkinsonism Relat Disord. 2017; (17) 30166-30169. Go to original source... Go to PubMed...
  2. Chang FC, Westerberger A, Dale RC, Smith M, Pall H, Perez-Duenas B, Grattan-Smith P, Ouvrier RA, Mahant N, Hanna BC, Hunter BC, Lawson JA, Max C, Sachdev R, Meyer E, Crimmins D, Pryor D, Morris JG, Münchau A, Grozeva D, Carss KJ, Raymond L, Kurian MA, Fung VS Phenotypic insights into ADCY5-associated disease. Mov Disord. 2016; 31(7): 1033-1040. Go to original source... Go to PubMed...
  3. Chen DH, Méneret A, Friedman JR, Korvatska O, Gad A, Bonkowski ES, Stessman HA, Doummar D, Mignot C, Anheim M, Bernes S, Davis MY, Damon-Perri?re N, Degos B, Grabli D, Gras D, Hisama FM, Mackenzie KM, Swanson PD, Tranchant C, Vidailhet M, Winesett S, Trouillard O, Amendola LM, Dorschner MO, Weiss M, Eichler, Torkamani A, Roze E, Bird TD, Raskind WH. ADCY5-related dyskinesia: Broader spectrum and genotype-phenotype correlations. Neurology. 2015; 85(23): 2026-235. Go to original source... Go to PubMed...
  4. Chen YZ, Matsushita MM, Robertson P, Rieder M, Girirajan S, Antonacci F, Lipe H, Eichler EE, Nickerson DA, Bird TD, Raskind WH. Autosomal dominant familial dyskinesia and facial myokymia: single exome sequencing identifies a mutation in adenylyl cyclase 5. Arch Neurol. 2012; 69(5): 630-635. Go to original source... Go to PubMed...
  5. Cooper DMF. Regulation and organization of adenylyl cyclases and cAMP. Biochem J. 2003; 375: 517-529. Go to original source... Go to PubMed...
  6. Douglas AGL, Andreoletti G, Talbot K, Hammans AR, Singh J, Whitney A, Ennis S, Foulds NC. ADCY5-related dyskinesia presenting as familial myoclonus-dystonia. Neurogenetics. 2017; 18: 111-117. Go to original source... Go to PubMed...
  7. Dy ME, Chang FC, Jesus SD, Anselm I, Mahant N, Zeilman P, Rodan LH, Foote KD, Tan W, Eskandar E, Sharma N, Okun MS, Fung VS, Waugh JL. Treatment of ADCY5-Associated Dystonia, Chorea, and Hyperkinetic Disorders with Deep Brain Stimulation: A Multicenter Case Series. J Child Neurol. 2016; 31(8): 1027-1035. Go to original source... Go to PubMed...
  8. Fernandez M, Raskind W, Wolff J, Matsushita M, Yuen E, Graf W, Lipe H, Bird T. Familial dyskinesia and facial myokymia (FDFM): a novel movement disorder. Ann Neurol. 2001; 49(4): 486-492. Go to original source...
  9. Friedman JR, Méneret A, Chen D-H, Trouillard O, Vidailhet M, Raskind WH, Roze E. ADCY5 Mutation Carriers Display Pleiotropic Paroxysmal Day and Nighttime Dyskinesias. Mov Disord. 2016; 31(1): 147-148. Go to original source... Go to PubMed...
  10. Gras D, Jonard L, Roze E, Chantot-Bastaraud S, Koht J, Motte J, Rodriguez D, Louha M, Caubel I, Kemlin I, Lion-François L, Goizet C, Guillot L, Moutard ML, Epaud R, Héron B, Charles P, Tallot M, Camuzat A, Durr A, Polak M, Devos D, Sanlaville D, Vuillaume I, Billette de Villemeur T, Vidailhet M, Doummar D. Benign hereditary chorea: phenotype, prognosis, therapeutic outcome and long-term follow-up in a large series with new mutations in the TITF1/NKX2-1 gene. J Neurol Neurosurg Psychiatr. 2012; 83(10): 956-962. Go to original source... Go to PubMed...
  11. Krägeloh-Mann I, Petruch U, Weber PM. Reference and Training Manual (R&TM) of the SCPE. Grenoble, Switzerland: Surveillance of Cerebral Palsy in Europe (SCPE); 2015.
  12. Meijer IA, Miravite J, Kopell BH, Lubarr N. Deep Brain Stimulation in an Additional Patient with ADCY5-Related Movement Disorder. J Child Neurol. 2017; 32(4): 438-439. Go to original source... Go to PubMed...
  13. Mencacci NE, Erro R, Wiethoff S, Hersheson J, Ryten M, Balint B, Ganos C, Stamelou M, Quinn N, Houlden H, Wood NW, Bhatia KP. ADCY5 mutations are another cause of benign hereditary chorea. Neurology. 2015 Jul 7; 85(1): 80-88. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.